Restoring the balance: Harnessing regulatory T cells for therapy in rheumatoid arthritis
Open Access
- 8 April 2008
- journal article
- viewpoints on-treg
- Published by Wiley in European Journal of Immunology
- Vol. 38 (4) , 934-937
- https://doi.org/10.1002/eji.200738107
Abstract
Treg play a vital role in the maintenance of tolerance to self antigens, thereby preventing disease through the active suppression of proliferation and pro‐inflammatory cytokine production by autoreactive T cells. Here we discuss strategies aimed at enhancing Treg function in patients with rheumatoid arthritis with the ultimate aim of restoring lasting tolerance but without increasing the risk of infections or cancer. See accompanying commentary: http://dx.doi.org/10.1002/eji.200838108Keywords
This publication has 33 references indexed in Scilit:
- Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responsesThe Journal of Experimental Medicine, 2007
- Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen‐induced arthritisArthritis & Rheumatism, 2007
- Therapeutic effect of urocortin on collagen‐induced arthritis by down‐regulation of inflammatory and Th1 responses and induction of regulatory T cellsArthritis & Rheumatism, 2007
- Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-βThe Journal of Experimental Medicine, 2007
- Modulation of T Cell Function by Combination of Epitope Specific and Low Dose Anticytokine Therapy Controls Autoimmune ArthritisPLOS ONE, 2006
- Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing TregsJournal of Clinical Investigation, 2006
- Transforming growth factor-β induces development of the TH17 lineageNature, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Increased Spontaneous Apoptosis of CD4+CD25+T Cells in Patients with Active Rheumatoid Arthritis Is Reduced by InfliximabAnnals of the New York Academy of Sciences, 2005
- Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα TherapyThe Journal of Experimental Medicine, 2004